Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis

Taher, 2011, Optimal management of beta thalassaemia intermedia, Br J Haematol, 512, 10.1111/j.1365-2141.2010.08486.x Taher, 2009, Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia, Br J Haematol, 569, 10.1111/j.1365-2141.2009.07810.x Taher, 2008, Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia, Haematologica, 1584, 10.3324/haematol.13098 Origa, 2007, Liver iron concentrations and urinary hepcidin in beta-thalassemia, Haematologica, 583, 10.3324/haematol.10842 Taher, 2009, Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies, Br J Haematol, 634, 10.1111/j.1365-2141.2009.07848.x Kowdley, 2004, Iron, hemochromatosis, and hepatocellular carcinoma, Gastroenterology, S79, 10.1016/j.gastro.2004.09.019 Mancuso, 2005, Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic, Am J Hematol, 158, 10.1002/ajh.20289 Mancuso, 2010, Hepatocellular carcinoma in thalassemia: A critical review, World J Hepatol, 171, 10.4254/wjh.v2.i5.171 Bradbear, 1985, Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases, J Natl Cancer Inst, 81 Fleming, 2002, Mechanisms of iron accumulation in hereditary hemochromatosis, Annu Rev Physiol, 663, 10.1146/annurev.physiol.64.081501.155838 Pietrangelo, 2007, Hemochromatosis: an endocrine liver disease, Hepatology, 1291, 10.1002/hep.21886 Chung, 2003, Hepatocellular carcinoma associated with secondary haemochromatosis in non-cirrhotic liver: a case report, Hepatol Res, 254, 10.1016/S1386-6346(03)00109-8 Stevens, 1988, Body iron stores and the risk of cancer, N Engl J Med, 1047, 10.1056/NEJM198810203191603 Herrinton, 1995, Transferrin saturation and risk of cancer, Am J Epidemiol, 692, 10.1093/oxfordjournals.aje.a117698 Moyo, 1998, African iron overload and hepatocellular carcinoma (HA-7-0-080), Eur J Haematol, 28 Turlin, 1995, Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver, Hepatology, 446 Ioannou, 2003, Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?, Clin Gastroenterol Hepatol, 246, 10.1016/S1542-3565(03)00126-5 Borgna-Pignatti, 2004, Hepatocellular carcinoma in the thalassaemia syndromes, Br J Haematol, 114, 10.1046/j.1365-2141.2003.04732.x Mancuso, 2006, A prospective study of hepatocellular carcinoma incidence in thalassemia, Hemoglobin, 119, 10.1080/03630260500455565 Restivo Pantalone, 2010, Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience, Br J Haematol, 245 Bruix, 2011, Management of hepatocellular carcinoma: an update, Hepatology, 1020, 10.1002/hep.24199 Musallam, 2011, Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia, Haematologica, 1605, 10.3324/haematol.2011.047852